Showing results (61-70 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|December 25, 2004
Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicinHooman Ganjavi, Matthew Gee, Aru Narendran, et al.Cancer Gene Therapy|October 16, 2004
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expressionHitoshi Fujiwara, Takeshi Kubota, Hisashi Amaike, et al.Cancer Gene Therapy|October 16, 2004
Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumorsXueying Sun, Haiquan Qiao, Hongchi Jiang, et al.Cancer Gene Therapy|October 16, 2004
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapyLoren W Noblitt, Dinesh S Bangari, Shruti Shukla, et al.Cancer Gene Therapy|January 25, 2005
Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex virusesMark A Currier, Lisa C Adams, Yonatan Y Mahller, et al.Cancer Gene Therapy|January 29, 2005
Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivoJeffrey A Medin, Sheng-Ben Liang, Jeannie Whit-Shan Hou, et al.Cancer Gene Therapy|January 15, 2005
Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapyDongfang Wang, Hangjun Ruan, Lily Hu, et al.Cancer Gene Therapy|February 12, 2005
Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft modelTomoko Ozawa, Jethro L Hu, Lily J Hu, et al.Cancer Gene Therapy|December 3, 2003
Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cellsHassan Adwan, Tobias J Bäuerle, Martin R BergerCancer Gene Therapy|December 19, 2003
hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatinMitsuhiro Nakamura, Satoru Kyo, Taro Kanaya, et al.Pageof 291